. Polypharmacy in Parkinson's disease: risks and benefits with little evidence. J Neural Transm (Vienna). 2019 Jul;126(7):871-878. Epub 2019 Jun 20 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.